Accuracy of Dopamine Transporter Imaging with 123I-Ioflupane in Hispanic and Non-Hispanic Patients
Authors:
Open Access
- 11 October 2019
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 48 (2) , 154-157
Abstract
Racial and ethnic disparities in the prevalence of neurodegenerative diseases exist. This study examines the agreement between gold standard diagnosis and visual assessment of dopamine transporter (DaT) imaging in Hispanic and non-Hispanic patients being evaluated for Parkinsonian syndromes (PS).Keywords
This publication has 12 references indexed in Scilit:
- Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or DementiaJournal of Nuclear Medicine, 2017
- Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of 123I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual ReadsJournal of Nuclear Medicine Technology, 2014
- Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitisClinical Immunology, 2011
- Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare BeneficiariesNeuroepidemiology, 2010
- Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECTMovement Disorders, 2009
- Epidemiology of Parkinson's diseaseThe Lancet Neurology, 2006
- Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/EthnicityAmerican Journal of Epidemiology, 2003
- [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophyMovement Disorders, 2001
- Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study groupMovement Disorders, 2000
- [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1997